Latest Morning Briefing Stories
No matter the outcome, the massive $69 billion deal between the pharmacy chain and the health insurer will likely transform the health care landscape if it gets final approval from state regulators.
And the report found that another 4,800 people are at risk at losing coverage if they don’t meet the work requirement by the end of this month. For critics of the requirements, it’s their worst fears realized. “This is an absolute train wreck, and it is a slow-moving train wreck that the state can stop at any time,” said Sam Brooke, deputy legal counsel for the Southern Poverty Law Center, one of three groups that had sued Arkansas over the mandate.
Democrats have been sounding warnings about the potential threat to preexisting conditions coverage on the trail for months. Now some Republicans are trying to get ahead of the issue through ads including family members with health problems. Meanwhile, President Donald Trump goes after Vermont Sen. Bernie Sanders’ “Medicare For All” plan.
The rule, which is part of President Donald Trump’s blueprint to rein in high drug costs, sparked immediate push back from pharmaceutical companies. Beyond the industry, experts are skeptical that the regulation would do anything to bring down prices and may confuse patients because consumers often don’t pay the list price for medications.
Editorial pages offer opinions on “Medicare For All,” the health law, mental illness, aging, and other health topics.
Media outlets report on news from Connecticut, Maryland, Illinois, California, New Hampshire, Massachusetts, Wisconsin, Louisiana and Texas.
Experts say drugmakers’ list prices are typically used as a starting point for negotiations with other health care payers and few patients are asked to pay them, so including may be confusing. HHS Secretary Alex Azar is scheduled to give a speech Monday afternoon that will address the administration’s blueprint for lowering drug costs.
“It’s crippling people. It’s crippling me,” Pennsylvania voter Kaci Rickert says of health care costs. The topic has taken center stage in the weeks before the midterm elections, as Democrats focus on Republicans’ threat to popular health law provisions, such as preexisting conditions protections, while Republicans go after progressives’ “Medicare For All” plan. News on the races comes out of Iowa, Ohio, California and Minnesota.
Media outlets report on news from Texas, Washington, Michigan, Maryland, California, Louisiana, Colorado, Minnesota, Wisconsin, Connecticut and Florida.
Editorial pages delve into the complexities of the health law, the marketplaces and what it all means for the elections.
The practice of lawmakers taking money from the health industries they regulate is not unusual, but the increased scrutiny of the opioid epidemic is drawing attention to these particular donations. News from the upcoming elections comes out of Iowa, California and Massachusetts, as well.
Pfizer will pay $500,000 in penalties, fees, and costs to New York, as well as more than $200,000 in restitution to consumers. The settlement comes amid ongoing controversy over the role that copay coupons play in rising health care costs
Step therapy allows insurers to require patients to try cheaper drugs first and see if they fail before moving on to more expensive ones. UnitedHealth has decided to require the method, which is supported by the Trump administration which rolled out new step therapy rules this year. Other pharmaceutical news includes Walgreens’ sales and biotech unicorns.
While Trump officials take credit for the dip in premiums, others warn that the numbers are just a small snapshot of the marketplaces and say that rates would have dropped more if not for some of the actions taken by the administration.
Media outlets report on news from Minnesota, Massachusetts, New York, Ohio, Kansas, California, Colorado, Arizona, Louisiana, Wisconsin and Florida.
The request from Sen. Chuck Grassley (R-Iowa) comes in response to a Wall Street Journal article that detailed hidden financial arrangements between hospital systems and insurers that included limitations on coverage offered by the plans to their enrollees, which in turn would save the hospitals money.
Centene will sell the health law plans in 20 states next year, adding Pennsylvania, North Carolina, South Carolina and Tennessee. It will also expand its markets in Florida, Georgia, Indiana, Kansas, Missouri and Texas.
The legislation won’t directly impact the prices of drugs, but it may lower what some consumers pay at the pharmacy. President Donald Trump’s signing was a contrast to the rancor over other health issues roiling through D.C.
Reports estimate that the ballot measure would cost the state’s health system more than $900 million a year, and that if it becomes law hospitals would need to hire as many as 3,100 additional full-time nurses to comply with the new mandate. Meanwhile, a poll finds that support for the measure is waning. Midterm election news comes out of Michigan, Minnesota and Maine, as well.
Democrats have seized on Republicans’ attacks on the health law — mostly focusing on preexisting conditions — as a winning strategy in the upcoming midterms. On Wednesday, senators forced a vote on blocking President Donald Trump’s short-term plan expansion, though no one really expected the measure to be approved. Still, the move put Republicans on the record as voting to uphold plans that don’t include health law protections just weeks before the 2018 elections.